Banor SIM
Banor SIM is a financial services firm based in Milan, Italy, specializing in capital management and advisory services tailored for high net worth individuals. The firm manages various investment funds, including the Banor Special Situations Fund, which focuses on credit opportunities with transaction values ranging from EUR 5 million to EUR 20 million. Additionally, Banor SIM oversees the Banor Private Opportunities Fund, a diversified private equity fund that invests across various regions, including the United States, Canada, and Asia. Through its specialized funds, Banor SIM aims to provide strategic investment solutions and enhance the financial portfolios of its clients.
Enthera S.r.l. is an Italian biotechnology company established in 2016, based in Milan, and operates as a subsidiary of BiovelocITA S.r.l. The company focuses on developing innovative biologics aimed at treating diabetes and its related gastrointestinal complications, particularly enteropathy, as well as other intestinal disorders that share similar biological pathways. Enthera's research is centered on monoclonal antibody discovery and biotherapeutics that target mechanisms involved in cell apoptosis in the gut, pancreas, and other organs. By addressing these pathways, Enthera aims to provide effective treatments for underserved autoimmune conditions, thereby contributing to advancements in the management of type 1 diabetes and inflammatory bowel disease. The company's name reflects its mission, combining the terms "entero," relating to the intestine, and "therapy."
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.